HNPCC Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
Condition:   Lynch Syndrome Intervention:   Drug: PD-1 Antibody Sponsors:   Sun Yat-sen University;   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Fujian Cancer Hospital;   Guangdong Provincial People's Hospital;   Guangdong Provincial Hospital of Traditional Chinese Medicine;   The Third Affiliated Hospital of Kunming Medical Colle ge. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2021 Category: Research Source Type: clinical trials